The med-tech industry remains resilient despite pressure from tariffs, supply chain challenges and shifting investor priorities, according to a report from Ernst & Young (EY). Companies in the U.S.

Eyepoint Inc. is cutting its workforce by about 53% and prioritizing its late-stage program for Duravyu (vorolanib intravitreal insert, EYP-1901) in diabetic macular edema, following a disappointing ...

Putting the February complete response letter firmly in the rearview mirror, Disc Medicine Inc. is gearing up for a second go at the U.S. FDA, this time on the back of positive top-line data from the ...

G2Gbio Inc. said it signed a platform evaluation agreement with United Biotechnology Co. Ltd. (UBT) to apply its microsphere ...

Buoyed by recent positive data for an autologous product, Nouscom AG has closed a €120 million (US$134.6 million) series D to ...

A decade ago, Amanda Randles and her colleagues could use a supercomputer to simulate only a few heartbeats through a patient’s cardiovascular anatomy. Duke University researchers now believe they ...

The Indian government issued a new drug pricing order that would impose a 30% cap on supply chain margins for 137 cancer drugs, expanding a 2019 pilot program that covered 42 cancer drugs.

For nearly three decades, the U.S. NIH has had the Office of Research on Women’s Health, which coordinates and supports ...

Darmstadt, Germany’s Merck KGaA agreed to acquire London’s Silence Therapeutics plc in an all-cash deal worth $1.3 billion in ...

T cells as potent killers of small-cell lung cancer (SCLC), with their genetic signature potentially revealing patients who ...

A consortium funded by the National Institutes of Health (NIH) has unveiled the most comprehensive map of somatic mosaicism ...

Revolution Medicines Inc.’s KRAS inhibitor, Rasonque (daraxonrasib), received a thumbs-up from the EMA’s Committee for ...